Invention Grant
US08088896B2 Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38
有权
对人CD38特异性的完全人类金衍生治疗性抗体的产生和分析
- Patent Title: Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38
- Patent Title (中): 对人CD38特异性的完全人类金衍生治疗性抗体的产生和分析
-
Application No.: US12089806Application Date: 2006-10-12
-
Publication No.: US08088896B2Publication Date: 2012-01-03
- Inventor: Michael Tesar , Ute Jäger
- Applicant: Michael Tesar , Ute Jäger
- Applicant Address: DE Martinsried
- Assignee: Morphosys AG
- Current Assignee: Morphosys AG
- Current Assignee Address: DE Martinsried
- Agency: Foley & Lardner LLP
- International Application: PCT/EP2006/009889 WO 20061012
- International Announcement: WO2007/042309 WO 20070419
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08
Abstract:
The present invention provides novel antibodies and functional fragments thereof specific for CD38, and methods for using the same. These antibodies as well as the novel methods for using those antibodies can be used to treat, for example, hematological malignancies such as multiple myeloma.
Public/Granted literature
- US20090252733A1 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38 Public/Granted day:2009-10-08
Information query
